[HTML] mdpi.com

[HTML][HTML] Interleukin-11: a potential biomarker and molecular therapeutic target in non-small cell lung cancer

JH Leung, B Ng, WW Lim - Cells, 2022 - mdpi.com
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …
被引用次数：8 相关文章

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

JH Leung, B Ng, WW Lim - 2022 - agris.fao.org
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …
[PDF] semanticscholar.org

[PDF][PDF] Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer. Cells 2022, 11, 2257

JH Leung, B Ng, WW Lim - 2022 - pdfs.semanticscholar.org
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer.

JH Leung, B Ng, WW Lim - Cells, 2022 - europepmc.org
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer.

JH Leung, B Ng, WW Lim - Cells (2073-4409), 2022 - search.ebscohost.com
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

JH Leung, B Ng, L Wei-Wen - Cells, 2022 - search.proquest.com
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

JH Leung, B Ng, WW Lim - Cells, 2022 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …
[HTML] nih.gov

[HTML][HTML] Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

JH Leung, B Ng, WW Lim - Cells, 2022 - ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …